#Liver disease

The Cyprus Association of Liver Patients “Promitheas” launched a new information campaign on Friday, focusing on the risks and prevention of fatty liver disease. According to the association, approximately 25 per ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) is recommending that the marketing authorisation for a liver disease drug be revoked because its benefits are no longer considered ...